Zymeworks Ownership | Who Owns Zymeworks?
Zymeworks Ownership Summary
Zymeworks is owned by 91.69% institutional investors, 1.31% insiders, and 7.00% retail investors. Ecor1 capital is the largest institutional shareholder, holding 30.76% of ZYME shares. HBM Healthcare Investments AG Ord is the top mutual fund, with 3.43% of its assets in Zymeworks shares.
ZYME Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Zymeworks | 91.69% | 1.31% | 7.00% |
| Sector | Healthcare Stocks | 244.37% | 12.11% | -156.48% |
| Industry | Biotech Stocks | 379.01% | 11.75% | -290.76% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ecor1 capital | 22.97M | 30.76% | $600.45M |
| Rubric capital management lp | 7.00M | 9.37% | $182.98M |
| Blackrock funding, inc. /de | 4.25M | 5.69% | $111.12M |
| Perceptive advisors | 4.18M | 5.60% | $109.34M |
| Bvf inc/il | 3.65M | 4.89% | $95.39M |
| Vanguard group | 2.33M | 3.07% | $61.32M |
| Morgan stanley | 2.23M | 2.99% | $58.33M |
| Bnp paribas asset management | 1.78M | 2.39% | $46.56M |
| Blackstone | 1.62M | 2.15% | $27.61M |
| Vanguard capital management | 1.56M | 2.09% | $40.75M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ecor1 capital | 22.97M | 29.19% | $600.45M |
| Prosight management, lp | 674.43K | 3.04% | $17.63M |
| Bvf inc/il | 3.65M | 2.44% | $95.39M |
| Aquilo capital management | 84.48K | 1.80% | $1.01M |
| Rubric capital management lp | 7.00M | 1.68% | $182.98M |
| Verdad advisers, lp | 66.69K | 1.67% | $1.74M |
| Perceptive advisors | 4.18M | 1.64% | $109.34M |
| Nextech invest | 1.11M | 1.38% | $29.12M |
| Capricorn fund managers | 486.53K | 1.00% | $12.72M |
| Manatuck hill partners | 100.00K | 0.87% | $2.61M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Macquarie management | 889.80K | 0.03% | 889.80K |
| Perceptive advisors | 4.18M | 1.64% | 672.88K |
| Assenagon asset management | 1.25M | 0.04% | 524.04K |
| First trust advisors lp | 340.36K | 0.01% | 340.36K |
| Pictet asset management sa | 308.19K | 0.01% | 298.93K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Siren | - | - | -1.68M |
| Vestal point capital, lp | - | - | -865.00K |
| Bridgeway capital management | - | - | -766.94K |
| Adage capital partners gp | - | - | -663.55K |
| Bioimpact capital | - | - | -565.25K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Macquarie management | 889.80K | 0.03% | 889.80K | $23.26M |
| First trust advisors lp | 340.36K | 0.01% | 340.36K | $8.90M |
| Axa investment managers | 158.42K | 0.01% | 158.42K | $2.71M |
| Sixth street partners management company | 152.42K | 0.00% | 152.42K | $3.98M |
| Aquilo capital management | 84.48K | 1.80% | 84.48K | $1.01M |
Sold Out
| Holder | Change |
|---|---|
| Mai capital management | -7.00 |
| Root financial partners | -12.00 |
| Northwestern mutual wealth management | -14.00 |
| Corecap advisors | -18.00 |
| Twin peaks wealth advisors | -20.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 206 | -6.79% | 68,461,250 | -2.59% | 91 | 1.05% | 88 | -23.48% | 72 | 18.03% |
| Mar 31, 2026 | 215 | -2.27% | 69,949,839 | -2.12% | 92 | 1.04% | 114 | -0.87% | 57 | -14.93% |
| Dec 31, 2025 | 88 | -53.68% | 14,118,121 | -80.85% | 18 | 0.19% | 53 | -44.21% | 20 | -65.52% |
| Sep 30, 2025 | 78 | -55.43% | 12,703,200 | -81.92% | 16 | 0.19% | 33 | -62.07% | 30 | -42.31% |
| Jun 30, 2025 | 183 | -2.14% | 75,607,117 | 7.41% | 100 | 1.15% | 90 | -3.23% | 54 | -15.63% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| HBM Healthcare Investments AG Ord | 2.52M | 3.43% | - |
| Vanguard US Total Market Shares ETF | 2.24M | 3.21% | - |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.51M | 2.10% | - |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.51M | 2.05% | -142.70K |
| Vanguard Total Stock Mkt Idx Inv | 1.51M | 2.05% | -142.70K |
| iShares Russell 2000 ETF | 1.18M | 1.65% | -21.02K |
| UBS (Lux) Digital Health Equity SB USD | 1.08M | 1.55% | - |
| BNP Paribas US Small Cap Classic R | 1.07M | 1.43% | -21.54K |
| BNP Paribas US Small Cap ClassicC | 991.27K | 1.35% | -1.67K |
| UBS Lux Dgtl Hlth Eq Fd seeding P acc | 844.70K | 1.12% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 12, 2026 | Hollywood Mark | EVP & Chief Operating Officer | Sell | $138.76K |
| Jan 12, 2026 | Smith Jeffrey T L | EVP & Chief Medical Officer | Sell | $211.09K |
| Jan 12, 2026 | Moore Paul Andrew | Chief Scientific Officer | Sell | $216.76K |
| Jan 12, 2026 | Galbraith Kenneth | Chair & CEO | Sell | $689.82K |
| Jan 05, 2026 | Smith Jeffrey T L | EVP & Chief Medical Officer | Sell | $264.47K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | - |
| 2026 Q2 | - | - |
| 2026 Q1 | - | 9 |
| 2025 Q4 | - | 1 |
| 2025 Q3 | - | - |
ZYME Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools